ICU Medical, Inc.
US ˙ NasdaqGS ˙ US44930G1076

SecurityICUI / ICU Medical, Inc.
InstitutionCerity Partners LLC
Latest Disclosed Ownership7,768 shares
Latest Disclosed Value $ 1,003,239
Cerity Partners LLC reports 10.14% increase in ownership of ICUI / ICU Medical, Inc.

On May 15, 2026 - Cerity Partners LLC filed a 13F-HR form disclosing ownership of 7,768 shares of ICU Medical, Inc. (US:ICUI) valued at $1,003,237 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 7,053 shares of ICU Medical, Inc.. This represents a change in shares of 10.14% during the quarter. The current value of the position is $1,013,879 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ICU MED COM 44930G107 7,768 715 10.14 1,003 -0.30 0.0007
2026-02-11 2025-12-31 13F ICU MED COM 44930G107 7,053 165 2.40 1,006 21.79 0.0015
2025-10-22 2025-09-30 13F ICU MED COM 44930G107 6,888 148 2.20 826 -7.19 0.0013
2025-08-13 2025-06-30 13F ICU MED Stock 44930G107 6,740 -2,215 -24.73 891 -28.40 0.0016
2025-04-30 2025-03-31 13F ICU MED Stock 44930G107 8,955 -328 -3.53 1,243 -23.98 0.0025
2025-02-13 2024-12-31 13F ICU MED Stock 44930G107 9,283 -563 -5.72 1,635 -8.86 0.0035
2024-11-12 2024-09-30 13F ICU MED Stock 44930G107 9,846 2,454 33.20 1,794 104.56 0.0040
2024-08-13 2024-06-30 13F ICU MED COM 44930G107 7,392 -619 -7.73 878 2.10 0.0023
2024-05-14 2024-03-31 13F ICU MED Equities 44930G107 8,011 8,011 860 0.0023
2019-08-14 2019-06-30 13F ICU MED COM 44930G107 0 -1,416 -100.00 0 -100.00
2019-05-14 2019-03-31 13F ICU MED COM 44930G107 1,416 61 4.50 339 9.00 0.0228
2019-02-06 2018-12-31 13F ICU MED COM 44930G107 1,355 400 41.88 311 15.19 0.0208
2018-11-15 2018-09-30 13F ICU MED COM 44930G107 955 -26 -2.65 270 -6.25 0.0187
2018-08-15 2018-06-30 13F ICU MED COM 44930G107 981 981 288 0.0213
2018-02-14 2017-12-31 13F ICU MED COM 44930G107 0 -1,725 -100.00 0 -100.00
2017-11-13 2017-09-30 13F ICU MED COM 44930G107 1,725 1,725 321 0.0227
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.